Literature DB >> 11161475

Reduced neuritic outgrowth and cell adhesion in neuronal cells transfected with human alpha-synuclein.

T Takenouchi1, M Hashimoto, L J Hsu, B Mackowski, E Rockenstein, M Mallory, E Masliah.   

Abstract

Since recent reports have suggested that alpha-synuclein might play a role in neuronal plasticity, the main objective of this study was to determine the effects of alpha-synuclein on neuritic outgrowth. We stably transfected either human (h) alpha- or beta-synuclein cDNA in B103 rat neuronal cells. Expression of h(alpha)-synuclein resulted in reduced neurite extension and weak adhesion compared to vector-transfected and h(beta)-synuclein expressing cells. To investigate the potential pathways involved, we studied the effects of reagents known to modulate B103 proliferation and differentiation. Neither phorbol 12-myristate 13-acetate nor forskolin or antioxidants (catalase, superoxide dismutase, or vitamin E) were able to restore the reduced length of neurites in h(alpha)-synuclein-expressing cells. These results suggest that reduced neuritic activity in the h(alpha)-synuclein-expressing cells might be due, in part, to alterations in cell adhesion capacity. This might be attributed to alpha-synuclein affecting a signal transduction pathway distinct from protein kinase C and protein kinase A.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11161475     DOI: 10.1006/mcne.2000.0923

Source DB:  PubMed          Journal:  Mol Cell Neurosci        ISSN: 1044-7431            Impact factor:   4.314


  26 in total

1.  Mutant alpha-synuclein exacerbates age-related decrease of neurogenesis.

Authors:  Beate Winner; Edward Rockenstein; D Chichung Lie; Robert Aigner; Michael Mante; Ulrich Bogdahn; Sebastien Couillard-Despres; Eliezer Masliah; Jürgen Winkler
Journal:  Neurobiol Aging       Date:  2007-01-31       Impact factor: 4.673

2.  Isolation of a human single chain antibody fragment against oligomeric alpha-synuclein that inhibits aggregation and prevents alpha-synuclein-induced toxicity.

Authors:  Sharareh Emadi; Hedieh Barkhordarian; Min S Wang; Philip Schulz; Michael R Sierks
Journal:  J Mol Biol       Date:  2007-03-07       Impact factor: 5.469

3.  Alpha-Synuclein Suppresses Retinoic Acid-Induced Neuronal Differentiation by Targeting the Glycogen Synthase Kinase-3β/β-Catenin Signaling Pathway.

Authors:  Sasuk Kim; Juhee Lim; Yeojin Bang; Jisook Moon; Min-Soo Kwon; Jin Tae Hong; Jeha Jeon; Hyemyung Seo; Hyun Jin Choi
Journal:  Mol Neurobiol       Date:  2017-02-11       Impact factor: 5.590

4.  Selective molecular alterations in the autophagy pathway in patients with Lewy body disease and in models of alpha-synucleinopathy.

Authors:  Leslie Crews; Brian Spencer; Paula Desplats; Christina Patrick; Amy Paulino; Edward Rockenstein; Lawrence Hansen; Anthony Adame; Douglas Galasko; Eliezer Masliah
Journal:  PLoS One       Date:  2010-02-19       Impact factor: 3.240

5.  Alpha-synuclein promotes early neurite outgrowth in cultured primary neurons.

Authors:  Guangwei Liu; Peng Wang; Xin Li; Yaohua Li; Shengli Xu; Kenji Uéda; Piu Chan; Shun Yu
Journal:  J Neural Transm (Vienna)       Date:  2013-02-27       Impact factor: 3.575

6.  Beta-Synuclein-derived peptides with neuroprotective activity: an alternative treatment of neurodegenerative disorders?

Authors:  Manfred Windisch; Birgit Hutter-Paier; Edith Schreiner; Robert Wronski
Journal:  J Mol Neurosci       Date:  2004       Impact factor: 3.444

7.  Axonopathy in an α-synuclein transgenic model of Lewy body disease is associated with extensive accumulation of C-terminal-truncated α-synuclein.

Authors:  Dora Games; Peter Seubert; Edward Rockenstein; Christina Patrick; Margarita Trejo; Kiren Ubhi; Benjamin Ettle; Majid Ghassemiam; Robin Barbour; Dale Schenk; Silke Nuber; Eliezer Masliah
Journal:  Am J Pathol       Date:  2013-01-09       Impact factor: 4.307

8.  Beclin 1 gene transfer activates autophagy and ameliorates the neurodegenerative pathology in alpha-synuclein models of Parkinson's and Lewy body diseases.

Authors:  Brian Spencer; Rewati Potkar; Margarita Trejo; Edward Rockenstein; Christina Patrick; Ryan Gindi; Anthony Adame; Tony Wyss-Coray; Eliezer Masliah
Journal:  J Neurosci       Date:  2009-10-28       Impact factor: 6.167

Review 9.  alpha-Synuclein: a therapeutic target for Parkinson's disease?

Authors:  Kathleen A Maguire-Zeiss
Journal:  Pharmacol Res       Date:  2008-09-16       Impact factor: 7.658

10.  Establishment of stably transfected rat neuronal cell lines expressing alpha-synuclein GFP fusion proteins.

Authors:  Gert Schwach; Michaela Tschemmernegg; Roswitha Pfragner; Elisabeth Ingolic; Edith Schreiner; Manfred Windisch
Journal:  J Mol Neurosci       Date:  2009-10-09       Impact factor: 3.444

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.